Abstract:Cucurbitacin B is a triterpenoid compound isolated from Trichosanthes kirilowii Maximowicz, which has been used in oriental medicine for its antitumor activities. However, the mechanisms by which cucurbitacin B inhibits tumor growth are not fully understood. We here demonstrated the effect of cucurbitacin B on hypoxia-inducible factor-1 (HIF-1) activation. Cucurbitacin B showed the potent inhibitory activity against HIF-1 activation induced by hypoxia in various human cancer cell lines. This compound markedly decreased the hypoxia-induced accumulation of HIF-1α protein dose-dependently, whereas it did not affect the expressions of HIF-1β. Further analysis revealed that cucurbitacin B inhibited HIF-1α protein synthesis, without affecting the expression level of HIF-1α mRNA or degradation of HIF-1α protein. Rather, we found that suppression of HIF-1α accumulation by cucurbitacin B correlated with strong dephosphorylation of mammalian target of rapamycin (mTOR) and its effectors ribosomal protein S6 kinase (p70S6K) and eukaryotic initiation factor 4E-binding protein-1 (4E-BP1) and extracellular signal-regulated kinase-1/2 (ERK1/2), a pathway known to regulate HIF-1α expression at the translational level. Cucurbitacin B also activated Akt, a mechanistic feature exhibited by established mTOR inhibitors in many tumor cells. Furthermore, cucurbitacin B prevented hypoxia-induced expression of HIF-1 target genes and suppresses the invasiveness of tumor cells. In vivo studies further confirmed the inhibitory effect of cucurbitacin B on the expression of HIF-1α proteins, leading to a decrease growth of HeLa cells in a xenograft tumor model. These results show that cucurbitacin B is an effective inhibitor of HIF-1 and provide new perspectives into the mechanism of its anticancer activity.

Cucurbitacin-I Induces Hypertrophy in H9c2 Cardiomyoblasts Through Activation of Autophagy Via MEK/ERK1/2 Signaling Pathway

Cucurbitacin-I induces hypertrophy in H9c2 cardiomyoblasts through activation of autophagy via MEK/ERK1/2 signaling pathway.

Cucurbitacin B Protects Against Pressure Overload Induced Cardiac Hypertrophy.

Cucurbitacin E Induces Autophagy Via Downregulating Mtorc1 Signaling and Upregulating AMPK Activity.

Cucurbitacin I Induces Cancer Cell Death Through the Endoplasmic Reticulum Stress Pathway.

Cucurbitacin B inhibits growth and induces apoptosis through the JAK2/STAT3 and MAPK pathways in SH‑SY5Y human neuroblastoma cells.

In Vitro and in Vivo Antitumor Activity of Cucurbitacin C, a Novel Natural Product from Cucumber

Cucurbitacin B induces DNA damage and autophagy mediated by reactive oxygen species (ROS) in MCF-7 breast cancer cells

Cucurbitacin B Inhibits the Translational Expression of Hypoxia-Inducible Factor-1Α.

Cucurbitacin B Inhibits Proliferation, Induces G2/M Cycle Arrest and Autophagy Without Affecting Apoptosis but Enhances MTT Reduction in PC12 Cells

Cucurbitacin I exerts its anticancer effects by inducing cell cycle arrest via the KAT2a-ube2C/E2F1 pathway and inhibiting HepG2-induced macrophage M2 polarization

Cucurbitacin E Induces Autophagy-Involved Apoptosis in Intestinal Epithelial Cells

Growth inhibitory effect of Cucurbitacin E on breast cancer cells.

Cucurbitacin B Induced ATM-Mediated DNA Damage Causes G2/M Cell Cycle Arrest in a ROS-Dependent Manner

Cucurbitacin E induces autophagy in HeLa cells by inhibiting mTORC1 activity

Cucurbitacin E Induces G<sub><b>2</b></sub>/M Phase Arrest through STAT3/p53/p21 Signaling and Provokes Apoptosis<i>via</i>Fas/CD95 and Mitochondria-Dependent Pathways in Human Bladder Cancer T24 Cells

Potential risk of hyperuricemia: leading cardiomyocyte hypertrophy by inducing autophagy.

Cucurbitacin E Induces G(2)/M Phase Arrest through STAT3/p53/p21 Signaling and Provokes Apoptosis via Fas/CD95 and Mitochondria-Dependent Pathways in Human Bladder Cancer T24 Cells.

Cucurbitacin B induces cell cycle arrest, apoptosis and autophagy associated with G actin reduction and persistent activation of cofilin in Jurkat cells.

Cucurbitacin E Induces G2/M Phase Arrest through STAT3/p53/p21 Signaling and Provokes Apoptosis via Fas/CD95 and Mitochondria-Dependent Pathways in Human Bladder Cancer T24 Cells

Targeted Constitutive Activation of Signal Transducer and Activator of Transcription 3 in Human Hepatocellular Carcinoma Cells by Cucurbitacin B